Perrigo | PRGO - Interest Expense On Debt


Perrigo reported $10.08B in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Abbott USD 42M 2M Dec/2025
Bayer EUR 762M 267M Sep/2025
Bristol-Myers Squibb USD 480M 5M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
J&J USD 18M 290M Sep/2025
Merck USD 327M 22M Sep/2025
Nestle CHF 929M 11M Jun/2025
Pacira USD 4.28M 456K Sep/2025
Perrigo USD 10.08B 10.04B Sep/2025
Pfizer USD 652M 2M Sep/2025
Prestige Brands USD 10.04M 167K Sep/2025
Reckitt Benckiser GBP 208M 198.3M Dec/2024
Sanofi EUR -25M 252M Dec/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 220M 17M Dec/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025
Zoetis USD 58M 5M Sep/2025